These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22926569)

  • 1. Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantum.
    Vale-Costa S; Vale N; Matos J; Tomás A; Moreira R; Gomes P; Gomes MS
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5774-81. PubMed ID: 22926569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
    Mesquita JT; Tempone AG; Reimão JQ
    Acta Trop; 2014 Feb; 130():112-6. PubMed ID: 24239532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial activity of antiretroviral drugs combined with miltefosine.
    Costa S; Machado M; Cavadas C; do Céu Sousa M
    Parasitol Res; 2016 Oct; 115(10):3881-7. PubMed ID: 27249967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis.
    Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF
    Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenocyanates and diselenides: a new class of potent antileishmanial agents.
    Plano D; Baquedano Y; Moreno-Mateos D; Font M; Jiménez-Ruiz A; Palop JA; Sanmartín C
    Eur J Med Chem; 2011 Aug; 46(8):3315-23. PubMed ID: 21571403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
    Pereira IAG; Mendonça DVC; Tavares GSV; Lage DP; Ramos FF; Oliveira-da-Silva JA; Antinarelli LMR; Machado AS; Carvalho LM; Carvalho AMRS; Salustiano IV; Reis TAR; Bandeira RS; Silva AM; Martins VT; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Duarte MC; Menezes-Souza D; Coimbra ES; Leite JPV; Coelho EAF; Gonçalves DU
    Parasite Immunol; 2020 Dec; 42(12):e12784. PubMed ID: 32772379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
    Bhattacharya A; Ouellette M
    EBioMedicine; 2018 Nov; 37():13-14. PubMed ID: 30314891
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
    González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
    Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids.
    Papanastasiou I; Prousis KC; Georgikopoulou K; Pavlidis T; Scoulica E; Kolocouris N; Calogeropoulou T
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5484-7. PubMed ID: 20719503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-cinnamoylated aminoquinolines as promising antileishmanial agents.
    Vale-Costa S; Costa-Gouveia J; Pérez B; Silva T; Teixeira C; Gomes P; Gomes MS
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5112-5. PubMed ID: 23917315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosine.
    Sousa MC; Varandas R; Santos RC; Santos-Rosa M; Alves V; Salvador JA
    PLoS One; 2014; 9(3):e89939. PubMed ID: 24643019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
    Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
    Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine.
    Yardley V; Gamarro F; Croft SL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5356-8. PubMed ID: 20837750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.